Cottage Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Cottage Street Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,869	Closed	-$220K	–	145
2025 Q3	$220K	Sell	4,869 -1,795	-27%	-$83.8K	0.09%	127
2025 Q2	$308K	Sell	6,664 -1,032	-13%	-$50.7K	0.16%	84
2025 Q1	$469K	Sell	7,696 -563	-7%	-$32.8K	0.23%	68
2024 Q4	$467K	Sell	8,259 -98	-1%	-$5.48K	0.24%	66
2024 Q3	$432K	Buy	8,357 +7	+0.1%	+$328	0.24%	66
2024 Q2	$347K	Sell	8,350 -316	-4%	-$14.1K	0.2%	71
2024 Q1	$470K	Sell	8,666 -93	-1%	-$4.74K	0.28%	59
2023 Q4	$454K	Sell	8,759 -293	-3%	-$15.4K	0.31%	56
2023 Q3	$525K	Buy	9,052 +5	+0.1%	+$306	0.38%	54
2023 Q2	$579K	Buy	9,047 +5	+0.1%	+$335	0.42%	50
2023 Q1	$627K	Buy	+9,042	New	+$638K	0.49%	50
2022 Q4	–	Sell	-8,983	Closed	-$639K	–	42
2022 Q3	$639K	Buy	8,983 +3	+0%	+$218	0.52%	47
2022 Q2	$691K	Buy	8,980 +36	+0.4%	+$2.74K	0.52%	50
2022 Q1	$653K	Buy	8,944 +4	+0%	+$269	0.39%	58
2021 Q4	$557K	Sell	8,940 -141	-2%	-$8.27K	0.32%	62
2021 Q3	$542K	Buy	9,081 +103	+1%	+$6.78K	0.36%	58
2021 Q2	$600K	Buy	8,978 +37	+0.4%	+$2.41K	0.36%	60
2021 Q1	$564K	Buy	8,941 +109	+1%	+$6.78K	0.37%	61
2020 Q4	$548K	Sell	8,832 -499	-5%	-$30.7K	0.51%	38
2020 Q3	$563K	Buy	9,331 +175	+2%	+$10.5K	0.41%	58
2020 Q2	$538K	Sell	9,156 -500	-5%	-$29.9K	0.4%	56
2020 Q1	$538K	Buy	9,656 +500	+5%	+$30.6K	0.48%	50
2019 Q4	$588K	Buy	9,156 +33	+0.4%	+$1.89K	0.33%	63
2019 Q3	$463K	Hold	9,123	–	–	0.28%	67
2019 Q2	$414K	Sell	9,123 -3,932	-30%	-$183K	0.25%	70
2019 Q1	$623K	Sell	13,055 -1,000	-7%	-$49.8K	0.38%	59
2018 Q4	$731K	Buy	14,055 +1,000	+8%	+$53.7K	0.49%	49
2018 Q3	$811K	Hold	13,055	–	–	0.46%	53
2018 Q2	$721K	Sell	13,055 -100	-0.8%	-$5.4K	0.42%	57
2018 Q1	$831K	Sell	13,155 -769	-6%	-$49.5K	0.51%	51
2017 Q4	$854K	Sell	13,924 -1,266	-8%	-$79.2K	0.51%	51
2017 Q3	$969K	Sell	15,190 -100	-0.7%	-$5.84K	0.62%	48
2017 Q2	$852K	Sell	15,290 -1,300	-8%	-$70.7K	0.58%	50
2017 Q1	$902K	Sell	16,590 -100	-0.6%	-$5.49K	0.64%	51
2016 Q4	$976K	Sell	16,690 -759	-4%	-$41.5K	0.74%	50
2016 Q3	$942K	Sell	17,449 -18,593	-52%	-$1.19M	0.73%	51
2016 Q2	$2.65M	Sell	36,042 -400	-1%	-$28.3K	2.15%	10
2016 Q1	$2.34M	Buy	36,442 +1,350	+4%	+$85.1K	2.04%	13
2015 Q4	$315K	Buy	+35,092	New	+$2.32M	0.28%	72

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Cottage Street Advisors's BMY Position: Q4 2025 in Review

Cottage Street Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 4,869 shares — an estimated $220K sold.

Cottage Street Advisors first reported a position in BMY in Q4 2015 and held it in 39 quarters. The position peaked at $2.65M in Q2 2016. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Cottage Street Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Cottage Street Advisors sold 4,869 Bristol-Myers Squibb shares in Q4 2025, an estimated $220K.
Cottage Street Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 39 quarters.
Cottage Street Advisors's Bristol-Myers Squibb position peaked at $2.65M in Q2 2016.
2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Cottage Street Advisors's 13F filing for Q4 2025, filed 26 Jan 2026.